CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study

被引:7
|
作者
Carriel, J. [1 ,6 ]
Munoz-Jaramillo, R. [2 ]
Bolanos-Ladinez, O. [3 ]
Heredia-Villacreses, F. [3 ]
Menendez-Sanchon, J. [4 ]
Martin-Delgado, J. [5 ]
机构
[1] Hosp Univ Zarzuela, Serv Med Interna, Madrid, Spain
[2] Hosp IESS Ceibos, Serv Gastroenterol, Guayaquil, Ecuador
[3] Hosp Clin San Francisco, Serv Cardiol, Serv Med Intens, Guayaquil, Ecuador
[4] Hosp Gen Guasmo Sur, Serv Med Interna, Guayaquil, Ecuador
[5] Fdn Fomento Invest Sanitaria & Biomed, Grp Invest Atenea, Alicante, Spain
[6] Univ Catolica Santiago Guayaquil, Fac Ciencias Med, Inst Invest & Innovat Salud Integral, Guayaquil, Ecuador
来源
REVISTA CLINICA ESPANOLA | 2022年 / 222卷 / 01期
关键词
Pneumonia; Coronavirus; SARS-CoV-2; COVID-19; CURB-65; Mortality; SCORE;
D O I
10.1016/j.rce.2020.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19. Methods: This work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador. Results: A total of 247 patients were included (mean age 60 +/- 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 >= 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress. Conclusions: CURB-65 >= 2 was associated with higher 30-day mortality on the univariate (Kaplan-Meier estimator) and multivariate (Cox regression) analysis. (C) 2020 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [31] Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19
    Nguyen, Yann
    Corre, Felix
    Honsel, Vasco
    Curac, Sonja
    Zarrouk, Virginie
    Fantin, Bruno
    Galy, Adrien
    JOURNAL OF INFECTION, 2020, 81 (03) : E96 - E98
  • [32] Reply to: Correspondence on "High rates of 30-day mortality in patients with cirrhosis and COVID-19"
    Iavarone, Massimo
    D'Ambrosio, Roberta
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1570 - 1571
  • [33] Letter regarding "High rates of 30-day mortality in patients with cirrhosis and COVID-19"
    Medhat, Mohammed A.
    El Kassas, Mohamed
    JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1569 - 1570
  • [34] Relationship of platelet counts, platelet volumes, and Curb-65 scores in the prognosis of COVID-19 patients
    Isler, Yesim
    Kaya, Halil
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 51 : 257 - 261
  • [35] Sex differences at different ages in 30-day survival of COVID-19 hospitalized patients in Israel
    Magid, A.
    Niv, Y.
    Green, M. S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [36] Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19
    Bertrand Guidet
    Christian Jung
    Hans Flaatten
    Jesper Fjølner
    Antonio Artigas
    Bernardo Bollen Pinto
    Joerg C. Schefold
    Michael Beil
    Sviri Sigal
    Peter Vernon van Heerden
    Wojciech Szczeklik
    Michael Joannidis
    Sandra Oeyen
    Eumorfia Kondili
    Brian Marsh
    Finn H. Andersen
    Rui Moreno
    Maurizio Cecconi
    Susannah Leaver
    Dylan W. De Lange
    Ariane Boumendil
    Intensive Care Medicine, 2022, 48 : 435 - 447
  • [37] Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19
    Guidet, Bertrand
    Jung, Christian
    Flaatten, Hans
    Fjolner, Jesper
    Artigas, Antonio
    Pinto, Bernardo Bollen
    Schefold, Joerg C.
    Beil, Michael
    Sigal, Sviri
    van Heerden, Peter Vernon
    Szczeklik, Wojciech
    Joannidis, Michael
    Oeyen, Sandra
    Kondili, Eumorfia
    Marsh, Brian
    Andersen, Finn H.
    Moreno, Rui
    Cecconi, Maurizio
    Leaver, Susannah
    De Lange, Dylan W.
    Boumendil, Ariane
    INTENSIVE CARE MEDICINE, 2022, 48 (04) : 435 - 447
  • [38] CURB65 may predict 30-day mortality in patients with bacteraemia
    Barlow, G.
    Lillie, P.
    Parsonage, M.
    Adams, K.
    Thaker, H.
    Moss, P.
    Meigh, J.
    Meigh, R.
    Mawer, S.
    Wilson, J.
    Dibb, W.
    Baruah, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S85 - S85
  • [39] The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry
    Lucijanic, Marko
    Zivkovic, Nevenka Piskac
    Rezic, Tanja
    Durlen, Ivan
    Stojic, Josip
    Jurin, Ivana
    Sakota, Sara
    Filipovic, Dora
    Kurjakovic, Iva
    Jordan, Ana
    Busic, Nikolina
    Pavic, Josipa
    Luksic, Ivica
    Barsic, Bruno
    CROATIAN MEDICAL JOURNAL, 2023, 64 (01) : 13 - 20
  • [40] Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia
    Murillo-Zamora, Efren
    Medina-Gonzalez, Alfredo
    Zamora-Perez, Liliana
    Vazquez-Yanez, Andres
    Guzman-Esquiyel, Jose
    Trujillo-Hernandez, Benjamin
    MEDICINA CLINICA, 2018, 150 (03): : 99 - 103